Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-21-003, Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa; Amended Notice of Meeting, 15672 [2021-06007]

Download as PDF 15672 Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Administration for Children and Families Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP21–003, Reducing Inequities in Cancer Outcomes Through Community-Based Interventions on Social Determinants of Health; Amended Notice of Meeting Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–IP–21– 003, Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID–19), and Other Respiratory Pathogens in South Africa; Amended Notice of Meeting Submission for OMB Review; Child Care and Development Fund (CCDF) ACF–696 Financial Report (OMB #0970–0163) Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP21– 003, Reducing Inequities in Cancer Outcomes through Community-Based Interventions on Social Determinants of Health; April 6–8, 2021, 10 a.m.–6 p.m., EST, in the original FRN. The teleconference meeting was published in the Federal Register on January 14, 2021, Volume 86, Number 9, pages 3157–3158. The meeting date, time, and contact information should read as follows: Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP–21–003, Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID–19), and Other Respiratory Pathogens in South Africa; May 13, 2021, 10 a.m.–5 p.m., EDT, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329–4027. The meeting was published in the Federal Register on January 11, 2021, Volume 86, Number 6, pages 1976–1977. The meeting is being amended to change the title and meeting dates of the special emphasis panel from RFA–IP– 21–003, Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID–19), and Other Respiratory Pathogens in South Africa; May 13, 2021, 10 a.m.–5 p.m., EDT to RFA–IP– 21–002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children; May 4–5, 2021, 10 a.m.–5 p.m., EDT. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027, (404) 718– 8833, ganderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Date: April 6, 2021 Time: 10 a.m.–6 p.m., EDT The meeting is closed to the public. Jaya Raman, Ph.D., Scientific Review Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop S107–8, Atlanta, Georgia 30341, telephone (770) 488–6511; JRaman@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: khammond on DSKJM1Z7X2PROD with NOTICES Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–06008 Filed 3–23–21; 8:45 am] BILLING CODE 4163–18–P Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–06007 Filed 3–23–21; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 16:30 Mar 23, 2021 Jkt 253001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Office of Child Care, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: The Administration for Children and Families (ACF) is requesting a 3-year extension of the form ACF–696: Child Care and Development Fund (CCDF) Quarterly Financial Report. This form is currently approved under the ACF Generic Clearance for Financial Reports (OMB #0970–0510; expiration May 31, 2021), and ACF is proposing to reinstate the previous OMB number under which this form had been approved. There are no changes requested to the form. DATES: Comments due within 30 days of publication. OMB must make a decision about the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Description: The ACF-696 Financial Report along with the instructions for completion of Form ACF–696, Financial Reporting Form for CCDF are being submitted for renewal with no changes. The form collects CCDF financial expenditures data for the 50 States, the District of Columbia, and five U.S. Territories that receive CCDF funding (American Samoa, Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and Virgin Islands). This report form is submitted quarterly by the referenced CCDF grant recipients. The form collects expenditures data for all respondents that receive CCDF funding. Respondents: The 50 States, the District of Columbia, and five U.S. Territories that receive CCDF funding (American Samoa, Commonwealth of SUMMARY: E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06007]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-21-003, Collaborative Research on 
Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory 
Pathogens in South Africa; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-21-003, Collaborative Research on Influenza, Coronavirus 
Disease 2019 (COVID-19), and Other Respiratory Pathogens in South 
Africa; May 13, 2021, 10 a.m.-5 p.m., EDT, Teleconference, Centers for 
Disease Control and Prevention, Room 1080, 8 Corporate Square 
Boulevard, Atlanta, Georgia 30329-4027. The meeting was published in 
the Federal Register on January 11, 2021, Volume 86, Number 6, pages 
1976-1977.
    The meeting is being amended to change the title and meeting dates 
of the special emphasis panel from RFA-IP-21-003, Collaborative 
Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other 
Respiratory Pathogens in South Africa; May 13, 2021, 10 a.m.-5 p.m., 
EDT to RFA-IP-21-002, US Enhanced Surveillance Network to Assess 
Burden, Natural History, and Effectiveness of Vaccines to Prevent 
Enteric and Respiratory Viruses in Children; May 4-5, 2021, 10 a.m.-5 
p.m., EDT. The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-06007 Filed 3-23-21; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.